282 related articles for article (PubMed ID: 23437178)
1. Imatinib ameliorates neuroinflammation in a rat model of multiple sclerosis by enhancing blood-brain barrier integrity and by modulating the peripheral immune response.
Adzemovic MV; Zeitelhofer M; Eriksson U; Olsson T; Nilsson I
PLoS One; 2013; 8(2):e56586. PubMed ID: 23437178
[TBL] [Abstract][Full Text] [Related]
2. Imatinib preserves blood-brain barrier integrity following experimental subarachnoid hemorrhage in rats.
Zhan Y; Krafft PR; Lekic T; Ma Q; Souvenir R; Zhang JH; Tang J
J Neurosci Res; 2015 Jan; 93(1):94-103. PubMed ID: 25196554
[TBL] [Abstract][Full Text] [Related]
3. Tyrosine kinase inhibitors ameliorate autoimmune encephalomyelitis in a mouse model of multiple sclerosis.
Crespo O; Kang SC; Daneman R; Lindstrom TM; Ho PP; Sobel RA; Steinman L; Robinson WH
J Clin Immunol; 2011 Dec; 31(6):1010-20. PubMed ID: 21847523
[TBL] [Abstract][Full Text] [Related]
4. Blocking PDGF-CC signaling ameliorates multiple sclerosis-like neuroinflammation by inhibiting disruption of the blood-brain barrier.
Zeitelhofer M; Adzemovic MZ; Moessinger C; Stefanitsch C; Strell C; Muhl L; Brundin L; Fredriksson L; Olsson T; Eriksson U; Nilsson I
Sci Rep; 2020 Dec; 10(1):22383. PubMed ID: 33361796
[TBL] [Abstract][Full Text] [Related]
5. PDGFR-α inhibition preserves blood-brain barrier after intracerebral hemorrhage.
Ma Q; Huang B; Khatibi N; Rolland W; Suzuki H; Zhang JH; Tang J
Ann Neurol; 2011 Dec; 70(6):920-31. PubMed ID: 22190365
[TBL] [Abstract][Full Text] [Related]
6. Lack of junctional adhesion molecule (JAM)-B ameliorates experimental autoimmune encephalomyelitis.
Tietz S; Périnat T; Greene G; Enzmann G; Deutsch U; Adams R; Imhof B; Aurrand-Lions M; Engelhardt B
Brain Behav Immun; 2018 Oct; 73():3-20. PubMed ID: 29920328
[TBL] [Abstract][Full Text] [Related]
7. The Emerging Role of Zinc in the Pathogenesis of Multiple Sclerosis.
Choi BY; Jung JW; Suh SW
Int J Mol Sci; 2017 Sep; 18(10):. PubMed ID: 28956834
[TBL] [Abstract][Full Text] [Related]
8. Longitudinal assessment of imatinib's effect on the blood-brain barrier after ischemia/reperfusion injury with permeability MRI.
Merali Z; Leung J; Mikulis D; Silver F; Kassner A
Transl Stroke Res; 2015 Feb; 6(1):39-49. PubMed ID: 25146090
[TBL] [Abstract][Full Text] [Related]
9. Immune cell trafficking across the barriers of the central nervous system in multiple sclerosis and stroke.
Lopes Pinheiro MA; Kooij G; Mizee MR; Kamermans A; Enzmann G; Lyck R; Schwaninger M; Engelhardt B; de Vries HE
Biochim Biophys Acta; 2016 Mar; 1862(3):461-71. PubMed ID: 26527183
[TBL] [Abstract][Full Text] [Related]
10. EGFL7 reduces CNS inflammation in mouse.
Larochelle C; Uphaus T; Broux B; Gowing E; Paterka M; Michel L; Dudvarski Stankovic N; Bicker F; Lemaître F; Prat A; Schmidt MHH; Zipp F
Nat Commun; 2018 Feb; 9(1):819. PubMed ID: 29483510
[TBL] [Abstract][Full Text] [Related]
11. Temporal expression and cellular origin of CC chemokine receptors CCR1, CCR2 and CCR5 in the central nervous system: insight into mechanisms of MOG-induced EAE.
Eltayeb S; Berg AL; Lassmann H; Wallström E; Nilsson M; Olsson T; Ericsson-Dahlstrand A; Sunnemark D
J Neuroinflammation; 2007 May; 4():14. PubMed ID: 17484785
[TBL] [Abstract][Full Text] [Related]
12. CCR2-dependent dendritic cell accumulation in the central nervous system during early effector experimental autoimmune encephalomyelitis is essential for effector T cell restimulation in situ and disease progression.
Clarkson BD; Walker A; Harris MG; Rayasam A; Sandor M; Fabry Z
J Immunol; 2015 Jan; 194(2):531-41. PubMed ID: 25505278
[TBL] [Abstract][Full Text] [Related]
13. Imatinib enhances functional outcome after spinal cord injury.
Abrams MB; Nilsson I; Lewandowski SA; Kjell J; Codeluppi S; Olson L; Eriksson U
PLoS One; 2012; 7(6):e38760. PubMed ID: 22723886
[TBL] [Abstract][Full Text] [Related]
14. Involvement of Claudin-11 in Disruption of Blood-Brain, -Spinal Cord, and -Arachnoid Barriers in Multiple Sclerosis.
Uchida Y; Sumiya T; Tachikawa M; Yamakawa T; Murata S; Yagi Y; Sato K; Stephan A; Ito K; Ohtsuki S; Couraud PO; Suzuki T; Terasaki T
Mol Neurobiol; 2019 Mar; 56(3):2039-2056. PubMed ID: 29984400
[TBL] [Abstract][Full Text] [Related]
15. Central nervous system penetration for small molecule therapeutic agents does not increase in multiple sclerosis- and Alzheimer's disease-related animal models despite reported blood-brain barrier disruption.
Cheng Z; Zhang J; Liu H; Li Y; Zhao Y; Yang E
Drug Metab Dispos; 2010 Aug; 38(8):1355-61. PubMed ID: 20427691
[TBL] [Abstract][Full Text] [Related]
16. Actin-Binding Protein Cortactin Promotes Pathogenesis of Experimental Autoimmune Encephalomyelitis by Supporting Leukocyte Infiltration into the Central Nervous System.
Samus M; Li YT; Sorokin L; Rottner K; Vestweber D
J Neurosci; 2020 Feb; 40(7):1389-1404. PubMed ID: 31911458
[TBL] [Abstract][Full Text] [Related]
17. Systemic administration of orexin A ameliorates established experimental autoimmune encephalomyelitis by diminishing neuroinflammation.
Becquet L; Abad C; Leclercq M; Miel C; Jean L; Riou G; Couvineau A; Boyer O; Tan YV
J Neuroinflammation; 2019 Mar; 16(1):64. PubMed ID: 30894198
[TBL] [Abstract][Full Text] [Related]
18. Protein kinase Cβ as a therapeutic target stabilizing blood-brain barrier disruption in experimental autoimmune encephalomyelitis.
Lanz TV; Becker S; Osswald M; Bittner S; Schuhmann MK; Opitz CA; Gaikwad S; Wiestler B; Litzenburger UM; Sahm F; Ott M; Iwantscheff S; Grabitz C; Mittelbronn M; von Deimling A; Winkler F; Meuth SG; Wick W; Platten M
Proc Natl Acad Sci U S A; 2013 Sep; 110(36):14735-40. PubMed ID: 23959874
[TBL] [Abstract][Full Text] [Related]
19. Expression of Ccl11 associates with immune response modulation and protection against neuroinflammation in rats.
Adzemovic MZ; Öckinger J; Zeitelhofer M; Hochmeister S; Beyeen AD; Paulson A; Gillett A; Thessen Hedreul M; Covacu R; Lassmann H; Olsson T; Jagodic M
PLoS One; 2012; 7(7):e39794. PubMed ID: 22815714
[TBL] [Abstract][Full Text] [Related]
20. Netrin 1 regulates blood-brain barrier function and neuroinflammation.
Podjaski C; Alvarez JI; Bourbonniere L; Larouche S; Terouz S; Bin JM; Lécuyer MA; Saint-Laurent O; Larochelle C; Darlington PJ; Arbour N; Antel JP; Kennedy TE; Prat A
Brain; 2015 Jun; 138(Pt 6):1598-612. PubMed ID: 25903786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
